dc.creatorEscobar E.L.O.
dc.creatorGomes-Marcondes M.C.C.
dc.creatorCarvalho H.F.
dc.date2009
dc.date2015-06-26T13:36:28Z
dc.date2015-11-26T15:36:47Z
dc.date2015-06-26T13:36:28Z
dc.date2015-11-26T15:36:47Z
dc.date.accessioned2018-03-28T22:45:15Z
dc.date.available2018-03-28T22:45:15Z
dc.identifier
dc.identifierProstate. , v. 69, n. 5, p. 548 - 558, 2009.
dc.identifier2704137
dc.identifier10.1002/pros.20905
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-61949483298&partnerID=40&md5=198b11b5b54dab3f3a46a6f7941f1db2
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/92550
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/92550
dc.identifier2-s2.0-61949483298
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1263513
dc.descriptionBACKGROUND. Fatty acids are among the most important nutritional factors associated with the ethiopathogenesis of prostate cancer, therefore the main objective of this work was to evaluate the effect of quality of fatty acid on the rat ventral prostate growth, tissue organization, and expression of androgen receptor (AR) and peroxisome proliferation activator receptor g (PPARγ). METHODS. Wistar rats were distributed into five groups, which were fed isocaloric normolipidic diets containing soybean oil (7% Control), linseed (7% or 3.5% linseed plus 3.5% soybean oil) and rendered pork fat (7% or 3.5% lard plus 3.5% soybean oil) for 10 weeks after weaning. RESULTS. At the end of treatment, the experiments demonstrated that lard and linseed oil caused opposite effects on prostatic growth. While the lard promoted an increase in prostatic weight associated to epithelial hyperplasia (confirmed by stereology); the linseed resulted in a significantly lighter organ. Immunohistochemistry and Western blotting demonstrated increased expression of AR and PPARγ in groups fed with lard diet, while linseed oil promoted a decrease. CONCLUSIONS. Prostatic growth is influenced by dietary fatty acids with concurrent variation in the expression of AR and PPARγ. PPARγ might represent the link between diet and prostate growth and AR expression and function. Since the levels of testosterone were altered it is also possible that prostatic changes are secondary to systemic effects of the diet. © 2009 Wiley-Liss, Inc.
dc.description69
dc.description5
dc.description548
dc.description558
dc.descriptionDhom, G., Epidemiologic aspects of latent and clinically manifest carcinoma of the prostate (1983) Journal of Cancer Research and Clinical Oncology, 106 (3), pp. 210-218
dc.descriptionChaudry, A., McClinton, S., Moffat, L.E.F., Wahle, K.W.J., Essential fatty acids distribution in the plasma and tissue phospholipids of patients with benign and malignant prostatic disease (1991) Br J Cancer, 64, pp. 1157-1160
dc.descriptionRowley, K.H., Mason, M.D., The aetiology and patogenesis of prostate cancer (1997) Clin Oncol R Coll Radiol, 9, pp. 213-218
dc.descriptionMamalakis, G., Kafatos, A., Karagelopoulos, N., Andrikolopoulos, N., Daskalopoulos, G., Kranidis, A., Prostate cancer vs hiperplasia: Relationships with prostatic and adipose tissue fatty acid composition (2002) Prostagl Leukotr Essent Fatty Acids, 66, pp. 467-477
dc.descriptionHankey, B.F., Feuer, E.J., Clegg, L.X., Hayes, R.B., Legler, J.M., Prorok, P.C., Ries, L.A., Kaplan, R.S., Cancer surveillance series: Interpreting trends in prostate cancer. Part I. Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates (1999) J Natl Cancer Inst, 91, pp. 1017-1024
dc.descriptionFleshner, N., Bagnell, P.S., Klotz, L., Venkateswaran, V., Kristal, A.R., Thompson, I.M., Klein, E., Ford, L.G., Dietary fat and prostate cancer (2004) Journal of Urology, 171 (2), pp. S19-S24. , DOI 10.1097/01.ju.0000107838.33623.19
dc.descriptionShennan, D.H., Bishop, O.S., Diet and the mortality from malignant disease in 32 countries (1974) West Indian Med J, 23, pp. 44-53
dc.descriptionBlair, A., Fraumeni Jr., J.F., Geographic patterns of prostate cancer in the United States (1978) Journal of the National Cancer Institute, 61 (6), pp. 1379-1384
dc.descriptionCarroll, K.K., Khor, H.T., Dietaty fat in relation to tumorigenesis (1975) Prog Biochem Pharmacol, 10, pp. 308-353
dc.descriptionKolonel, L.N., Nomura, A.M., Cooney, R.V., Dietary fat and prostate cancer: Current status (1999) J Natl Cancer Inst, 91, pp. 414-428
dc.descriptionMyers, C.E., Ghosh, J., Lipoxygenase inhibition in prostate cancer (1999) European Urology, 35 (5-6), pp. 395-398. , DOI 10.1159/000019915
dc.descriptionZhu, Y.S., Katz, M.D., McGinley, I., Lessons from human genetic models (1998) Bailleres Clin Endocrinol Metab, 12, pp. 83-113
dc.descriptionCunha, G.R., Donjacour, A.A., Cooke, P.S., Mee, S., Bigsby, R.M., Higgins, S.J., Sugimura, Y., The endocrinology and developmental biology of the prostate (1987) Endocr Rev, 8, pp. 338-362
dc.descriptionRoss, R.K., Henderson, B.E., Do diets and androgens alter prostate cancer risk via a common etiologic pathway? (1994) J Natl Cancer Inst, 86, pp. 252-254
dc.descriptionDorgan, J.F., Judd, J.T., Longcope, C., Brown, C., Schatzkin, A., Clevidence, B.A., Campbell, W.S., Taylor, P.R., Effects of dietary fat and fiber on plasma and urine androgens and estrogens in men: A controlled feeding study (1996) Am J Clin Nutr, 64, pp. 850-855
dc.descriptionIssemann, I., Green, S., Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators (1990) Nature, 347 (6294), pp. 645-650. , DOI 10.1038/347645a0
dc.descriptionZhang, B., Marcus, S.L., Sajjadi, F.G., Alvares, K., Reddy, J.K., Subramani, S., Rachubinski, R.A., Capone, J.P., Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase 3-hydroxyacyl-CoA- dehydrogenase (1992) Proc Natl Acad Sci USA, 89, pp. 7541-7545
dc.descriptionKrey, G., Braissant, O., L'Horset, F., Kalkhoven, E., Perroud, M., Parker, M.G., Wahli, W., Fatty acids eicosanoids are ligands for peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay (1997) Mol Endocrinol, 11, pp. 770-791
dc.descriptionSegawa, Y., Yoshimura, R., Hase, T., Hase, T., Nakatani, T., Wada, S., Kawahito, Y., Sano, H., Expression of peroxisome proliferator-activated receptor (PPAR) in human prostate cancer (2002) Prostate, 51, pp. 108-116
dc.descriptionWillson, T.M., Lambert, M.H., Kliewer, S.A., Peroxisome proliferator-activated receptor gamma and metabolic disease (2001) Annual Review of Biochemistry, 70, pp. 341-367. , DOI 10.1146/annurev.biochem.70.1.341
dc.descriptionSporn, M.B., Suh, N., Mangelsdorf, D.J., Prospects for prevention and treatment of cancer with selective PPARgamma modulators (SPARMs) (2001) Trends in Molecular Medicine, 7 (9), pp. 395-400. , DOI 10.1016/S1471-4914(01)02100-1, PII S1471491401021001
dc.descriptionRosen, E.D., Spiegelman, B.M., PPARgamma: A Nuclear Regulator of Metabolism, Differentiation, and Cell Growth (2001) Journal of Biological Chemistry, 276 (41), pp. 37731-37734
dc.descriptionNwankwo, J.O., Robbins, M.E.C., Peroxisome proliferator-activated receptor-gamma expression in human malignant and normal brain, breast and prostate-derived cells (2001) Prostaglandins Leukotrienes and Essential Fatty Acids, 64 (4-5), pp. 241-245. , DOI 10.1054/plef.2001.0266
dc.descriptionHan, S., Roman, J., Peroxisome proliferator-activated receptor gamma: A novel target for cancer therapeutics? (2007) Anticancer Drugs, 18 (3), pp. 237-244
dc.descriptionMueller, E., Smith, M., Sarraf, P., Kroll, T., Aiyer, A., Kaufman, D.S., Oh, W., Kantoff, P.W., Effects of ligand activation of peroxisome proliferator-activated receptor g human prostate cancer (2000) Proc Natl Acad Sci USA, 97, pp. 10990-10995
dc.descriptionBuyukbabani, N., Mitchell, S.H., Tindall, D.J., Young, C.Y.F., Non-apoptotic cell death associated with S-phase arrest of prostate cancer cells via peroxisome proliferator-activated receptor γ ligand, 15-deoxy-12,14-prostaglandin J12 (2000) Cell Growth Differ, 11, pp. 49-61
dc.descriptionLi, W.-D., Lee, J.H., Price, R.A., The peroxisome proliferator-activated receptor gamma2 Pro12Ala mutation is associated with early onset extreme obesity and reduced fasting glucose (2000) Molecular Genetics and Metabolism, 70 (2), pp. 159-161. , DOI 10.1006/mgme.2000.2999
dc.descriptionReeves, P.G., Nielsen, F.H., Fahey Jr., G.C., AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet (1993) J Nutr, 123, pp. 1939-1951
dc.descriptionKondo, Y., Homma, Y., Aso, Y., Kakizoe, T., Promotional effect of two-generation exposure to a high-fat diet on prostate carcinogenesis in ACI/Seg rats (1994) Cancer Research, 54 (23), pp. 6129-6132
dc.descriptionWang, Y., Corr, J.G., Thaler, H.T., Tao, Y., Fair, W.R., Heston, W.D., Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet (1995) J Natl Cancer Inst, 87, pp. 1456-1462
dc.descriptionGarcia-Florez, M., Oliveira, C.A., Carvalho, H.F., Early effects of estrogen on the rat ventral prostate (2005) Brazilian Journal of Medical and Biological Research, 38 (4), pp. 487-497
dc.descriptionVilamaior, P.S.L., Taboga, S.R., Carvalho, H.F., Postnatal growth of the ventral prostate in Wistar rats: A stereological and morphometrical study (2006) Anat Rec, 288 A, pp. 885-892
dc.descriptionFritz, W.A., Wang, J., Eltoum, I.-E., Lamartiniere, C.A., Dietary genistein down-regulates androgen and estrogen receptor expression in the rat prostate (2002) Molecular and Cellular Endocrinology, 186 (1), pp. 89-99. , PII S0303720701006633
dc.descriptionGad, S.C., Weil, C.S., Statistic for toxicologists (1994) Principles and Methods of Toxicology, pp. 221-274. , Wallace H, editor. New York: Raven Press
dc.descriptionGiles, G., Ireland, P., Diet, nutrition and prostate cancer (1997) International Journal of Cancer, 72 (SUPPL.), pp. 13-17
dc.descriptionCai, X., Haleem, R., Oram, S., Cyriac, J., Jiang, F., Grayhack, J.T., Kozlowski, J.M., Wang, Z., High fat diet increases the weight of rat ventral prostate (2001) Prostate, 49 (1), pp. 1-8. , DOI 10.1002/pros.1112
dc.descriptionCai, G., Huang, H., Shapiro, E., Zhou, H., Yeh, S., Melamed, J., Greco, M.A., Lee, P., Expression of androgen receptor associated protein 55 (ARA55) in the developing human fetal prostate (2005) Journal of Urology, 173 (6), pp. 2190-2193. , DOI 10.1097/01.ju.0000158119.34126.70
dc.descriptionWahle, K.W., Heys, S.D., Cell signal mechanisms, conjugated linoleic acids (CLAs) and anti-tumorigenesis (2002) Prostagl Leukotr Essent Fatty Acids, 67, pp. 183-186
dc.descriptionBidoli, E., Talamini, R., Bosetti, C., Negri, E., Maruzzi, D., Montella, M., Franceschi, S., La Vecchia, C., Macronutrients, fatty acids, cholesterol and prostate cancer risk (2005) Ann Oncol, 16, pp. 152-157
dc.descriptionFeldman, B.J., Feldman, D., The development of androgen-independent prostate cancer (2001) Nature Reviews Cancer, 1 (1), pp. 34-45
dc.descriptionSciarra, F., Toscano, V., Role of estrogens in human benign prostatic hyperplasia (2000) Archives of Andrology, 44 (3), pp. 213-220
dc.descriptionHåå G, P., Bektic, J., Bartsch, G., Klocker, H., Eder, I.E., Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells (2005) J Steroid Biochem Mol Biol, 96, pp. 251-258
dc.descriptionFreeman, V.L., Meydani, M., Hur, K., Flanigan, R.C., Inverse association between prostatic polyunsaturated fatty acid and risk of locally advanced prostate carcinoma (2004) Cancer, 101 (12), pp. 2744-2754. , DOI 10.1002/cncr.20676
dc.descriptionBravi, F., Bosetti, C., Dal Maso, L., Talamini, R., Montella, M., Negri, E., Ramazzotti, V., La Vecchia, C., Food groups and risk of benign prostatic hyperplasia (2006) Urology, 67 (1), pp. 73-79. , DOI 10.1016/j.urology.2005.07.030, PII S009042950501126X
dc.descriptionHardman, W.E., (n-3) fatty acids and cancer therapy (2004) J Nutr, 134 (12 SUPPL.), pp. 3427S-3430S
dc.descriptionKota, B.P., Huang, T.H.-W., Roufogalis, B.D., An overview on biological mechanisms of PPARs (2005) Pharmacological Research, 51 (2), pp. 85-94. , DOI 10.1016/j.phrs.2004.07.012, PII S104366180400194X
dc.descriptionSubbarayan, V., Sabichi, A.L., Kim, J., Llansa, N., Logothetis, C.J., Lippman, S.M., Menter, D.G., Differential peroxisome proliferator-activated receptor-γ isoform expression and agonist effects in normal and malignant prostate cells (2004) Cancer Epidemiology Biomarkers and Prevention, 13 (11), pp. 1710-1716
dc.descriptionCury-Boaventura, F.M., Kanunfre, C.C., Gorjão, R., Martins De Lima, T., Curi, R., Mechanisms involved in Jurkat cell death induced by oleic and linoleic acids (2006) Clin Nutr, 25, pp. 1004-1014
dc.descriptionSampath, H., Ntambi, J.M., Polyunsaturated fatty acid regulation of gene expression (2004) Nutrition Reviews, 62 (9), pp. 333-339. , DOI 10.1301/nr.2004.sept.333-339
dc.descriptionMurtaugh, M.A., Ma, K.-N., Caan, B.J., Sweeney, C., Wolff, R., Samowitz, W.S., Potter, J.D., Slattery, M.L., Interactions of peroxisome proliferator-activated receptor, and diet in etiology of colorectal cancer (2005) Cancer Epidemiology Biomarkers and Prevention, 14 (5), pp. 1224-1229. , DOI 10.1158/1055-9965.EPI-04-0681
dc.languageen
dc.publisher
dc.relationProstate
dc.rightsfechado
dc.sourceScopus
dc.titleDietary Fatty Acid Quality Affects Ar And Pparγ Levels And Prostate Growth
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución